Search research articles
Contact Us
Filters
Showing results (71-80 of 136) with videos related to
Page
of 14
Sort By:
JTO Clinical and Research Reports
|
November 19, 2025
DLL3 Immunohistochemical Expression in Neuroendocrine-Transformed <i>EGFR</i>-Mutant Lung Cancer and Two Cases of Tarlatamab Therapy
Jacqueline V Aredo, Surbhi Singhal, Gerald J Berry, et al.
JTO Clinical and Research Reports
|
June 9, 2025
A Phase 1/1B Trial of Pembrolizumab and Trametinib in Advanced NSCLC Enriched for KRAS Mutations
Jonathan W Riess, Matthew S Lara, Guillaume Luxardi, et al.
JCO Precision Oncology
|
May 26, 2021
Phase I/II Study of Capmatinib Plus Erlotinib in Patients With MET-Positive Non-Small-Cell Lung Cancer
Caroline E McCoach, Aiming Yu, David R Gandara, et al.
Cancer
|
May 5, 2020
Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non-small cell lung cancer: Analysis of over 8000 cases
Philip C Mack, Kimberly C Banks, Carin R Espenschied, et al.
JTO Clinical and Research Reports
|
September 25, 2024
Immune Cell Dynamics in EGFR-Mutated NSCLC Treated With Afatinib and Pembrolizumab: Results From a Phase IB Study
Jonathan W Riess, Matthew S Lara, Miguel Lopez de Rodas, et al.
Clinical Lung Cancer
|
June 18, 2021
Erlotinib and Onalespib Lactate Focused on EGFR Exon 20 Insertion Non-Small Cell Lung Cancer (NSCLC): A California Cancer Consortium Phase I/II Trial (NCI 9878)
Jonathan W Riess, Karen L Reckamp, Paul Frankel, et al.
Science Advances
|
July 21, 2023
Satellite reveals a steep decline in China's CO<sub>2</sub> emissions in early 2022
Hui Li, Bo Zheng, Philippe Ciais, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 27, 2019
Phase II trial of single agent amrubicin in patients with previously treated advanced thymic malignancies
Jessica A Hellyer, Matthew A Gubens, Kristen M Cunanan, et al.
Journal of Thoracic Imaging
|
December 9, 2017
Computed Tomography Features associated With the Eighth Edition TNM Stage Classification for Thymic Epithelial Tumors
Sukhmani K Padda, Donato Terrone, Lu Tian, et al.
The Oncologist
|
August 9, 2019
MET Genomic Alterations in Head and Neck Squamous Cell Carcinoma (HNSCC): Rapid Response to Crizotinib in a Patient with HNSCC with a Novel <i>MET</i> R1004G Mutation
Lisa Pei Chu, Debra Franck, Christine A Parachoniak, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 136) with videos related to
Sort By:
Page
of 14
JTO Clinical and Research Reports
|
November 19, 2025
DLL3 Immunohistochemical Expression in Neuroendocrine-Transformed <i>EGFR</i>-Mutant Lung Cancer and Two Cases of Tarlatamab Therapy
Jacqueline V Aredo, Surbhi Singhal, Gerald J Berry, et al.
JTO Clinical and Research Reports
|
June 9, 2025
A Phase 1/1B Trial of Pembrolizumab and Trametinib in Advanced NSCLC Enriched for KRAS Mutations
Jonathan W Riess, Matthew S Lara, Guillaume Luxardi, et al.
JCO Precision Oncology
|
May 26, 2021
Phase I/II Study of Capmatinib Plus Erlotinib in Patients With MET-Positive Non-Small-Cell Lung Cancer
Caroline E McCoach, Aiming Yu, David R Gandara, et al.
Cancer
|
May 5, 2020
Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non-small cell lung cancer: Analysis of over 8000 cases
Philip C Mack, Kimberly C Banks, Carin R Espenschied, et al.
JTO Clinical and Research Reports
|
September 25, 2024
Immune Cell Dynamics in EGFR-Mutated NSCLC Treated With Afatinib and Pembrolizumab: Results From a Phase IB Study
Jonathan W Riess, Matthew S Lara, Miguel Lopez de Rodas, et al.
Clinical Lung Cancer
|
June 18, 2021
Erlotinib and Onalespib Lactate Focused on EGFR Exon 20 Insertion Non-Small Cell Lung Cancer (NSCLC): A California Cancer Consortium Phase I/II Trial (NCI 9878)
Jonathan W Riess, Karen L Reckamp, Paul Frankel, et al.
Science Advances
|
July 21, 2023
Satellite reveals a steep decline in China's CO<sub>2</sub> emissions in early 2022
Hui Li, Bo Zheng, Philippe Ciais, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 27, 2019
Phase II trial of single agent amrubicin in patients with previously treated advanced thymic malignancies
Jessica A Hellyer, Matthew A Gubens, Kristen M Cunanan, et al.
Journal of Thoracic Imaging
|
December 9, 2017
Computed Tomography Features associated With the Eighth Edition TNM Stage Classification for Thymic Epithelial Tumors
Sukhmani K Padda, Donato Terrone, Lu Tian, et al.
The Oncologist
|
August 9, 2019
MET Genomic Alterations in Head and Neck Squamous Cell Carcinoma (HNSCC): Rapid Response to Crizotinib in a Patient with HNSCC with a Novel <i>MET</i> R1004G Mutation
Lisa Pei Chu, Debra Franck, Christine A Parachoniak, et al.
Page
of 14